Fu'an Qingsong Future Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Fu'an Qingsong Future Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RELAX FUTURE. The owner is based in Fu'an City, Fujian Province.

Room 803, Building 2, Zhongjian Fanghuali, No. 3 Wufu Avenue, Xitan Town

Fu'an City, Fujian Province 355000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Fu'an Qingsong Future Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Fu'an Qingsong Future Technology Co., Ltd. have?

Fu'an Qingsong Future Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Fu'an Qingsong Future Technology Co., Ltd. file in?

Fu'an Qingsong Future Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Fu'an Qingsong Future Technology Co., Ltd.'s most well-known trademarks?

Fu'an Qingsong Future Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as RELAX FUTURE. These are among 1 currently registered trademark in the portfolio.

What is Fu'an Qingsong Future Technology Co., Ltd.'s trademark registration success rate?

Fu'an Qingsong Future Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.